| 0 (0%) | 09-27 09:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.67 | 1-year : | 5.09 |
| Resists | First : | 4 | Second : | 4.36 |
| Pivot price | 3.84 |
|||
| Supports | First : | 3.42 | Second : | 2.84 |
| MAs | MA(5) : | 3.8 |
MA(20) : | 3.8 |
| MA(100) : | 4.07 |
MA(250) : | 6.84  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 37.1 |
D(3) : | 37.8 |
| RSI | RSI(14): 50.4 |
|||
| 52-week | High : | 26.79 | Low : | 2.29 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BLRX ] has closed above bottom band by 49.7%. Bollinger Bands are 47% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.86 - 3.88 | 3.88 - 3.89 |
| Low: | 3.61 - 3.63 | 3.63 - 3.65 |
| Close: | 3.81 - 3.84 | 3.84 - 3.87 |
Sun, 21 Sep 2025
Guidance Update: Is BLRX forming a breakout pattern - Layoff News & Community Consensus Trade Alerts - خودرو بانک
Fri, 15 Aug 2025
BLRX: ASCO Poster & Abstract - Zacks Small Cap Research
Thu, 14 Aug 2025
BioLineRx Plans New Drug Pipeline Deal as Cash Runway Stretches to 2027 - Stock Titan
Thu, 14 Aug 2025
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire
Thu, 07 Aug 2025
BioLineRx Q2 2025 Earnings: Oncology Biotech Developer Updates Investors Next Week - Stock Titan
Wed, 09 Jul 2025
Why Investors Shouldn't Be Surprised By BioLineRx Ltd.'s (TLV:BLRX) 29% Share Price Plunge - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 4 (M) |
| Shares Float | 2,450 (M) |
| Held by Insiders | 4 (%) |
| Held by Institutions | 1.5 (%) |
| Shares Short | 181 (K) |
| Shares Short P.Month | 166 (K) |
| EPS | -6 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -45.4 % |
| Operating Margin | -757.6 % |
| Return on Assets (ttm) | -15.4 % |
| Return on Equity (ttm) | -46 % |
| Qtrly Rev. Growth | -94.5 % |
| Gross Profit (p.s.) | 2.4 |
| Sales Per Share | 4.04 |
| EBITDA (p.s.) | -2.55 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -21 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -0.64 |
| PEG Ratio | 0 |
| Price to Book value | 384 |
| Price to Sales | 0.94 |
| Price to Cash Flow | -0.78 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|